WHO vaccine-preventable diseases: monitoring system. 2019 global summary

Last updated 10-December-2019 (data as of 10-December-2019)
Next overall update June 2020
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 1 Infant (under 12 months) mortality rate: 632
GDP / capita (US$): 1 Child (under 5 years) mortality rate: 962

Population data in thousands3

  2018  2017  2016  2015  2014  2000  1990  1980 
Total population 10'976  10'911  10'833  10'716  10'555  6'199  5'493  4'503 
Births 387  386  384  383  380  265  253  218 
Surviving infants 362  361  360  358  355  237  218  182 
Pop. less than 5 years 1'702  1'712  1'718  1'717  1'718  1'104  997  811 
Pop. less than 15 years 4'590  4'589  4'579  4'553  4'516  2'779  2'431  1'997 
Female 15-49 years 3'098  3'007  2'916  2'825  2'729  1'508  1'323  1'081 

Number of reported cases

(Click for retrospective incidence data for South Sudan)
Diphtheria
ChartChart
 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  263  487  898  878  441 
Mumps
ChartChart
 
Pertussis
ChartChart
 
Polio*
ChartChart
 
Rubella
ChartChart
  106  72  47 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
 
Yellow fever
ChartChart
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for South Sudan)
Vaccine year result method % card seen                                                
BCG 2016  52  EPI   24  52  62  52  58  61 
DTP1 2016  51  EPI   24  51  77  58  60  72 
DTP3 2016  49  EPI   24  49  59  45  50  58 
IPV1          39  54  34 
HepB_BD         
HepB3 2016  49  EPI   24  49  59  45  55 
Hib3 2016  49  EPI   24  49  59  45  55 
JapEnc         
MCV1          49  75  51  70  52 
MCV2         
MenA         
PCV1         
PCV2         
PCV3         
Pol3 2016  50  EPI   24  50  58  45  55  58 
Rota1         
RotaC         
RCV1         
TT2plus 2011  65  EPI   51  44  49  38  28  45 
PAB         
VAD1          87 
YFV         
* indicates the country reported above 100% coverage.

  Next update: Mid July 2020

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for South Sudan)
BCG
ChartChart
  52  52  52  55  55 
DTP1
ChartChart
  58  58  58  55  62 
DTP3
ChartChart
  49  47  45  46  50 
HepB3
ChartChart
  49  47  45  31 
HepB_BD
ChartChart
 
Hib3
ChartChart
  49  47  45  31 
IPV1
  34  34  34 
MCV1
ChartChart
  51  51  51  53  55 
MCV2
 
PCV3
 
Pol3
ChartChart
  50  48  45  52  52 
RCV1
 
RotaC
 
YFV
 

Click to download WHO-UNICEF coverage estimates data for PAB time series.
Click to download WHO-UNICEF coverage estimates data for HPV time series.

Number of districts in the country 80  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
89 
   
/
|
|
\
Greater or equal to 90% 21
From 80 to 89% 5
From 50 to 79% 24
Less than 50% 49
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2018 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
IPV 14 weeks; Yes
Measles 9 months; Yes
OPV 6, 10, 14 weeks; Yes
TT First contact; +1, +6 months; +1, +1 year; Yes 15-45 years

Immunizaton indicators

Indicator Expected answer 2018  2017  2016  2015  2014  2013  2012 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2018 - 2022  2018-2022  2'016  2012-2016  2012-2016  2012-2016  2012- 2016 
Nº of districts with microplans that include activities to raise immunization coverage number 60  80  43  43  80  80 

System performance

Total Nº districts in country number 80  80    80  80  80  80 
Nº districts with DTP3 coverage >=80% number 21  24  11  31  20  18  33 
% of districts with DTP3 coverage >=80% From 0 to 100% 26  30    39  25  23  41 
Nº districts with measles (MCV1) coverage >=95% number 18  25  20  28  27  36 
% of districts with MCV1 coverage >=95% From 0 to 100% 23  31    25  35  34  45 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes    No  No  No 
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  No    No  No  No 

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100% 20  11     

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  No 

Sources

 1  "The 2019 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  UN Inter-agency Group for Child Mortality Estimation (https://childmortality.org/data)  
 3  "United Nations, Population Division. The World Population Prospects - the 2019 revision". New York, 2019.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.